Letter to Editor Regarding “Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast” by Seijnhaeve et al

Tomonori Kawasaki, MD, PhD1, Tomoaki Tashima, MD, PhD2, Yasuhiro Nakamura, MD, PhD3, Tetsuo Kondo, MD, PhD4, Atsushi Enomoto, MD, PhD5, Kyoichi Kaira, MD, PhD6

1Department of Pathology, Saitama Medical University International Medical Center, Hidaka, Japan

2Department of Gastroenterology, Saitama Medical University International Medical Center, Hidaka, Japan

3Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Hidaka, Japan

4Department of Pathology, University of Yamanashi, Yamanashi, Japan

5Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan

6Department of Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka, Japan


Corresponding Author:

Tomonori Kawasaki, Department of Pathology, Saitama Medical University International Medical Center, 1397-1, Yamane, Hidaka, Saitama 350-1298, Japan. Email:

View original article
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Comments (0)

No login
gif
format_indent_decrease